Ecolab
Ecolab's revenue rose 2.2% to $16.1 billion in fiscal 2025. Its operating margin was 17.0%, down from 17.8% a year earlier. Free cash flow was $1.9 billion, up 4.7%. It paid out $1.5 billion in dividends and buybacks, 81% of free cash flow. The diluted share count fell 0.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 6.5% a year and net income 5.8% a year, as buybacks cut the share count by 4%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Ecolab yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Ecolab's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Ecolab's fiscal 2025 free cash flow of $1.9B, net cash of −$7.6B at December 31, 2025 and 285 million diluted shares, from its filings. The scenarios are fitted to Ecolab: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 4.3% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11% for a cyclical or higher-risk business (Specialty Chemicals); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $288.89
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Ecolab's earnings per share of $7.45 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 30.9×, the middle of Ecolab's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 12%, 11% and 10%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $288.89
- Value at this multiple, against the last close
- —
- Ecolab's P/E at the last close
- 38.8×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| International Flavors & FragrancesIFF | $93.69 | $1.14 | 82.2× |
| EcolabECL | $288.89 | $7.45 | 38.8× |
| Sherwin-WilliamsSHW | $335.16 | $10.85 | 30.9× |
| PPG IndustriesPPG | $109.90 | $7.02 | 15.7× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 360 | 599 | 920 | 1,257 | 646 |
| Debt incl. finance leases | 8,758 | 8,580 | 8,182 | 7,565 | 8,236 |
| Net debt (negative means net cash) | 8,398 | 7,982 | 7,262 | 6,308 | 7,590 |
| Net debt to EBITDA | 3.4x | 3.2x | 2.5x | 1.7x | 2.0x |
| Debt to equity | 1.2x | 1.2x | 1.0x | 0.9x | 0.8x |
| Interest coverage | 6.9x | 6.2x | 5.7x | 8.2x | 8.9x |
| Current ratio | 1.3x | 1.3x | 1.3x | 1.3x | 1.1x |
| Quick ratio | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 4 insiders bought $3.9 million of Ecolab shares on the open market, and 10 insiders sold $27.1 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Eric Mark GreenDirector | Bought | 3,690 | $276.64 | $1.0 million | Form 4 |
| Aug 18, 2026 | Christophe BeckChairman, President & CEO, Director | Sold | 17,862 | $280.14 | $5.0 million | Form 4 |
| Aug 11, 2026 | Gregory B CookCo-COO - Global Businesses | Sold | 4,567 | $285.13 | $1.3 million | Form 4 |
| Jul 30, 2026 | Scott D KirklandChief Financial Officer | Sold | 3,357 | $276.96 | $929,755 | Form 4 |
| Jun 11, 2026 | Benjamin M. ClarkEVP - Global Supply Chain | Bought | 1,000 | $263.83 | $263,830 | Form 4 |
| Jun 10, 2026 | Michel D DoukerisDirector | Bought | 7,750 | $258.00 | $2.0 million | Form 4 |
| Jun 9, 2026 | Darrell R BrownCo-COO - Global Markets | Sold | 10,000 | $260.89 | $2.6 million | Form 4 |
| May 27, 2026 | Suzanne M VautrinotDirector | Sold | 1,004 | $264.98 | $266,040 | Form 4 |
| May 13, 2026 | David MacLennanDirector | Bought | 1,000 | $250.65 | $250,650 | Form 4 |
| May 4, 2026 | David MacLennanDirector | Bought | 800 | $256.91 | $205,528 | Form 4 |
| Feb 26, 2026 | Gregory B CookEVP & Pres - Inst Group | Sold | 3,519 | $304.25 | $1.1 million | Form 4 |
| Feb 25, 2026 | Tracy B McKibbenDirector | Sold | 1,265 | $308.66 | $390,455 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Fail | Fail | Fail |
| Share count didn't rise | Pass | Fail | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | 8 of 9 | 7 of 9 | 5 of 9 |
| Accruals ratio | −4.8% | −3.2% | −3.7% |
Compare
Put Ecolab side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Ecolab | FY25 | 2.2% | 17.0% | 11.8% | 13.8% | 2.0x | 5 | |
| PPG Industries | FY25 | 0.2% | — | 7.3% | 14.4% | 1.8x | 7 | Compare |
| Westlake | FY25 | −8.0% | −14.1% | −4.7% | −10.0% | — | 3 | Compare |
| Sherwin-Williams | FY25 | 2.1% | — | 11.3% | 19.9% | 2.4x | 6 | Compare |
| International Flavors & Fragrances | FY25 | −5.2% | −3.5% | 2.4% | −1.4% | 9.4x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 13,152 | 13,836 | 12,222 | 12,562 | 11,790 | 12,733 | 14,188 | 15,320 | 15,741 | 16,081 |
| Revenue growth | −2.9% | 5.2% | −11.7% | 2.8% | −6.1% | 8.0% | 11.4% | 8.0% | 2.8% | 2.2% |
| Gross profit | 5,618 | 5,772 | 5,347 | 5,516 | 4,884 | 5,117 | 5,357 | 6,165 | 6,842 | 7,150 |
| Research and development | 189 | 201 | 193 | 190 | 185 | 186 | 190 | 192 | 207 | 202 |
| Operating income | 1,870 | 1,950 | 1,728 | 1,845 | 1,396 | 1,599 | 1,562 | 1,992 | 2,802 | 2,738 |
| Net income | 1,246 | 1,519 | 1,440 | 1,576 | −1,186 | 1,130 | 1,092 | 1,372 | 2,112 | 2,076 |
| Diluted EPS (US$) | 4.14 | 5.12 | 4.88 | 5.33 | −4.15 | 3.91 | 3.81 | 4.79 | 7.37 | 7.28 |
| Diluted shares (millions) | 297 | 294 | 293 | 292 | 290 | 289 | 287 | 286 | 287 | 285 |
| Cash flow | ||||||||||
| Cash from operations | 1,940 | 2,091 | 2,278 | 2,421 | 1,860 | 2,062 | 1,788 | 2,412 | 2,814 | 2,953 |
| Capital expenditure | 757 | 869 | 779 | 731 | 489 | 643 | 713 | 775 | 994 | 1,048 |
| Free cash flow | 1,183 | 1,223 | 1,499 | 1,689 | 1,371 | 1,419 | 1,076 | 1,637 | 1,819 | 1,904 |
| Dividends paid | 428 | 449 | 495 | 553 | 561 | 566 | 603 | 617 | 664 | 754 |
| Share buybacks | 740 | 600 | 562 | 354 | 146 | 107 | 518 | 14 | 986 | 784 |
| Acquisitions | 85 | 989 | 230 | 391 | 487 | 3,924 | 7 | 180 | 313 | 1,621 |
| Stock-based compensation | 86 | 90 | 88 | 84 | 82 | 90 | 88 | 95 | 135 | 137 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 327 | 211 | 115 | 119 | 1,260 | 360 | 599 | 920 | 1,257 | 646 |
| Debt incl. finance leases | 6,687 | 7,323 | 7,045 | 6,354 | 6,687 | 8,758 | 8,580 | 8,182 | 7,565 | 8,236 |
| Total assets | 18,330 | 19,964 | 20,074 | 20,869 | 18,126 | 21,206 | 21,464 | 21,847 | 22,388 | 24,696 |
| Total liabilities | 11,359 | 12,310 | 12,021 | 12,143 | 11,924 | 13,953 | 14,206 | 13,774 | 13,599 | 14,892 |
| Shareholders' equity | 6,901 | 7,584 | 8,003 | 8,685 | 6,166 | 7,224 | 7,236 | 8,045 | 8,757 | 9,771 |
| Margins and ratios | ||||||||||
| Gross margin | 42.7% | 41.7% | 43.8% | 43.9% | 41.4% | 40.2% | 37.8% | 40.2% | 43.5% | 44.5% |
| Operating margin | 14.2% | 14.1% | 14.1% | 14.7% | 11.8% | 12.6% | 11.0% | 13.0% | 17.8% | 17.0% |
| Net margin | 9.5% | 11.0% | 11.8% | 12.6% | −10.1% | 8.9% | 7.7% | 9.0% | 13.4% | 12.9% |
| Free cash flow margin | 9.0% | 8.8% | 12.3% | 13.4% | 11.6% | 11.1% | 7.6% | 10.7% | 11.6% | 11.8% |
| Return on capital | 10.6% | 12.0% | 9.3% | 10.3% | 8.9% | 9.5% | 8.3% | 10.3% | 15.3% | 13.8% |
| Return on equity | 18.1% | 21.0% | 18.5% | 18.9% | −16.0% | 16.9% | 15.1% | 18.0% | 25.1% | 22.4% |
| Return on assets | 6.7% | 7.9% | 7.2% | 7.7% | −6.1% | 5.8% | 5.1% | 6.3% | 9.6% | 8.8% |
| Net debt to EBITDA | 2.3x | 2.5x | 2.8x | 2.4x | 2.5x | 3.4x | 3.2x | 2.5x | 1.7x | 2.0x |